1. European Medicines Agency. Applications for New Human Medicines Under Evaluation by the Committee for Medicinal Products for Human Use: April 2012 <
http://www.ema.europa.eu/docs/en_GB/document_library/Report/2012/04/WC500125365.pdf
> (EMA, London, 2012).
2. European Medicines Agency. Guideline on Similar Biological Medicinal Products Containing Monoclonal Antibodies—Non-Clinical and Clinical Issues EMA/CHMP/BMWP/403543/2010. <
http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2012/06/WC500128686.pdf
> (EMA, London, 2012).
3. Schneider, C.K. & Kalinke, U. Nat. Biotechnol. 26, 985–990 (2008).
4. European Medicines Agency. EMEA Workshop on Monoclonal Antibodies, London, UK. <
http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/events/2009/11/event_detail_000013.jsp&mid=WC0b01ac058004d5c3
> (2 July 2009).
5. European Medicines Agency. Concept Paper on the Development of a Guideline on Similar Biological Medicinal Products Containing Monoclonal Antibodies EMEA/CHMP/BMWP/632613/2009. <
http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/11/WC500014438.pdf
> (EMA, London, UK, 2009).